Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin.
about
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degenerationAntioxidant vitamin and mineral supplements for slowing the progression of age-related macular degenerationLutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye DiseaseMacular pigment in retinal health and diseaseMacular xanthophylls, lipoprotein-related genes, and age-related macular degenerationWhat is meso-zeaxanthin, and where does it come from?Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death.The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disordersAugmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.Siansivirga zeaxanthinifaciens gen. nov., sp. nov., a novel zeaxanthin-producing member of the family Flavobacteriaceae isolated from coastal seawater of Taiwan.Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration.The effect of lutein- and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers.Verification of Meso-Zeaxanthin in Fish.Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.Association of macular pigment optical density with risk factors for wet age-related macular degeneration in the Indian population.Macular pigment spatial distribution effects on glare disability.Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease StudyThe role of lutein in eye-related diseaseLooking beyond Lucentis on the management of macular degeneration.Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins.Lutein and Zeaxanthin Isomers in Eye Health and Disease.Macular pigment optical density spatial distribution measured in a subject with oculocutaneous albinism.Caco-2 accumulation of lutein is greater from human milk than from infant formula despite similar bioaccessibility.A supplementation study in human subjects with a combination of meso-zeaxanthin, (3R,3'R)-zeaxanthin and (3R,3'R,6'R)-lutein.Scientific Opinion on the substantiation of health claims related to meso-zeaxanthin and maintenance of vision (ID 2096) pursuant to Article 13(1) of Regulation (EC) No 1924/2006Efficacy of Diacetate Esters of Macular Carotenoids: Effect of Supplementation on Macular Pigment.
P2860
Q24202824-840EEF96-0CEE-4B7D-9A79-201FAD20869FQ24246241-2B6A879D-868D-4DFB-BB55-9060702DBB63Q26773085-D711758D-594E-4EA4-816A-A4E02BDABA94Q28072398-F2C33F2E-16DC-4EFB-8ED6-28B9C1446E9DQ28240096-0AFC6F42-E962-4799-8AD4-3EF744203672Q28291367-4C62F89F-1C86-4654-ADFF-898954B45B5EQ33720330-3BA10FB2-40E5-42FD-8FD6-EED990E20A17Q33733227-3C9BC804-91E9-454A-80B6-2A9051B0E26CQ34108927-C0EB0890-4050-449B-9F88-0E5716FC9A7AQ34267778-2F8D8847-0DFE-46F2-8F7C-927F738CBFD1Q34315578-E039F0CA-58C2-458E-A629-1B6988EDF22BQ34635706-1E04D005-26A2-443E-9615-AB6205ADC190Q35112300-59B7B991-5535-4346-93F4-D94153771E93Q36078526-B65AACBD-EC79-4588-BD0F-3EAD560E810AQ36093266-C82C9D45-DF76-49ED-A7F8-94A25BA3A8A4Q36114384-42F1F34B-27E0-4A0D-B915-A7AB3FD3B8AFQ36766616-F26BE658-D87B-47C1-AC33-5236578D1F93Q37002600-B50FAEFC-253B-4342-80E5-5C0EE9A792E6Q37054887-8538A160-76D8-4E14-B7BC-C49B5ED14BB4Q37537304-9B7C6F54-A704-4F01-84A9-09ECEA3BD555Q38653249-22FC9B58-E55B-42FA-9497-A551CFA3B9CBQ38751193-00CA8A06-29C0-4500-8868-2E5B5987028FQ38901504-86C81526-4BB9-4361-8B44-AD18FB537635Q42057260-E3C67F78-F0E4-495F-BA2D-C785EE096C6BQ44076259-E61F9CD8-F475-46FC-A65E-E25630290102Q46650038-F97553E6-7DCC-4B0A-A75A-08A69CE41E13Q47147946-F78E32AA-99E7-4403-977F-0A10D764307CQ54965109-65E4485C-5F48-4FD9-B641-9F57C41593B7
P2860
Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@ast
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@en
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@nl
type
label
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@ast
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@en
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@nl
prefLabel
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@ast
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@en
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@nl
P2093
P2860
P356
P1476
Macular pigment response to a ...... anthin, lutein and zeaxanthin.
@en
P2093
Alan N Howard
Francesca Alvarez-Calderon
John T Landrum
Richard A Bone
P2860
P2888
P356
10.1186/1743-7075-4-12
P577
2007-05-11T00:00:00Z
P5875
P6179
1029490589